Cardiobridge
Cardiobridge GmbH is a privately held German medical device company that develops and manufactures the 10F-Reitan Catheter Pump, a percutaneous ventricular assist device (pVAD) for mechanical circulatory support in acute heart failure, sold to hospitals and cardiac care centers.
- Company typePrivate
- Founded2016
- HeadquartersHechingen, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Cardiobridge firmographics
Firmographics- Name
- Cardiobridge
- Legal name
- Cardiobridge GmbH
- Website
- https://cardiobridge.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cardiobridge GmbH is a privately held German medical device company that develops and manufactures the 10F-Reitan Catheter Pump, a percutaneous ventricular assist device (pVAD) for mechanical circulatory support in acute heart failure, sold to hospitals and cardiac care centers.
- Ownership category
- akta.pro rank
Cardiobridge industry classification
Industry- Product category
- Mechanical Circulatory Support Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Mechanical Circulatory Support (VAD, IABP, ECMO) (HLAHAFAG)
- akta.pro secondary industry
- Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation) (HLAHAFAL)
Keywords
Where Cardiobridge is headquartered
LocationHeadquarters
- HQ city
- Hechingen
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Cardiobridge business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Medical Device Sales: Cardiobridge generates revenue through the sale of its 10F-Reitan Catheter Pump and associated console systems to hospitals and cardiac care centers for acute heart failure treatment. As a medical device company, this likely involves direct hospital procurement with potential recurring revenue from accessories, disposables, and service agreements.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Cardiobridge product offering
Product offeringCore offering
Cardiobridge designs, manufactures, and sells the 10F-Reitan Catheter Pump, a percutaneous ventricular assist device (pVAD) that delivers mechanical circulatory support for patients in acute heart failure. The system includes a catheter pump inserted via a 10F introducer sheath into the femoral artery, paired with a portable touchscreen console for control and monitoring. It is sold to hospitals and cardiac care centers for use in acute decompensated heart failure treatment.
Product overview
Cardiobridge offers a single unified product — the 10F-Reitan Catheter Pump — a percutaneous Mechanical Circulatory Support (pVAD) device. The system consists of the catheter pump (inserted via a 10F introducer sheath into the femoral artery) and a portable console (8 kg with battery backup) featuring a touchscreen interface for control and monitoring. The product targets acute decompensated heart failure patients and is designed to prevent further decompensation by providing sufficient circulatory support.
Differentiator
Problem solved
Functional benefit
Products and services
- 10F-Reitan Catheter Pump Percutaneous ventricular assist device (pVAD) that delivers mechanical circulatory support for patients in acute decompensated heart failure, combining a minimal-invasive 10F femoral introducer profile with high pumping performance and assisting both heart and kidney function. Targets hospitals and cardiac care centers treating acute heart failure patients.
Companies that use Cardiobridge
Customer profileSegments1 record
Ideal customer profiles1 record
Cardiobridge technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Cardiobridge partnerships and signals
Strategic signalScale indicators1 record
Recent moves4 records
Expansion highlights3 records
Cardiobridge competitors and assessment
Company assessmentEmerging players
- Magenta Medical: Israel-based developer of transcatheter heart pumps for short-term mechanical circulatory support. Directly comparable as a smaller, venture-backed innovator in the pVAD/heart pump space targeting similar acute heart failure indications.
- Evaheart Inc. Developer of a next-generation centrifugal LVAD for long-term mechanical circulatory support. Overlaps in the mechanical circulatory support category, though focused on durable LVAD rather than acute pVAD.
Broad incumbents
- Medtronic: Medtronic is a broad cardiovascular incumbent offering heart pumps, surgical cannulae, and other cardiac surgery devices. It represents the diversified MedTech scale player that competes for hospital mechanical circulatory support business across multiple acute and long-term indications.
- Getinge (Maquet): Getinge, through Maquet, offers cardiac surgery equipment including cannulae, grafts, and perfusion systems used alongside mechanical circulatory support. Comparable as a hospital cardiovascular equipment vendor serving cardiac surgery and ICU customers.
- Terumo Cardiovascular: Terumo manufactures perfusion and cardiovascular surgery products including cannulae and pumps used in cardiopulmonary support. Comparable as a broad cardiovascular device manufacturer whose products may be deployed alongside or in lieu of a pVAD in cardiac surgery settings.
- LivaNova (TLC / Caisson): LivaNova operates in cardiac surgery and heart failure with mechanical circulatory support offerings (Caisson interventional mitral, prior TLC programs). Comparable as a cardiovascular device incumbent serving similar hospital customers.
- Abbott (Cardiac Assist / HeartMate): Abbott manufactures mechanical circulatory support devices including HeartMate 3 (LVAD) and CentriMag (used for short-term support). While predominantly an LVAD player, Abbott competes for the same hospital budgets and patient populations targeted by Cardiobridge's acute pVAD.
- Abiomed (J&J MedTech): Now part of Johnson & Johnson MedTech, Abiomed is the dominant manufacturer of percutaneous ventricular assist devices including the Impella family. It is the closest direct competitor in the pVAD category and the benchmark Cardiobridge's 10F-Reitan Catheter Pump must compete against in hospitals.
Direct peers
- Berlin Heart: Germany-based developer of ventricular assist devices (EXCOR and others) for pediatric and adult heart failure patients. Berlin Heart is a direct regional peer with overlapping mechanical circulatory support focus and shared European clinical footprint.
- SynCardia Systems: Manufacturer of the total artificial heart (TAH) and related mechanical circulatory support systems. Direct peer in the VAD / mechanical circulatory support category targeting patients with advanced heart failure.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights5 records
Customer concentration
Cardiobridge social profiles
Digital presenceCardiobridge financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cardiobridge leadership team
Management profileNumber of profiles
Profiles1 record
Cardiobridge funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cardiobridge M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cardiobridge
What does Cardiobridge do?
Cardiobridge designs, manufactures, and sells the 10F-Reitan Catheter Pump, a percutaneous ventricular assist device (pVAD) that delivers mechanical circulatory support for patients in acute heart failure. The system includes a catheter pump inserted via a 10F introducer sheath into the femoral artery, paired with a portable touchscreen console for control and monitoring. It is sold to hospitals and cardiac care centers for use in acute decompensated heart failure treatment.
Is Cardiobridge a public or private company?
Cardiobridge is a private company. It is classified as unknown and is currently operating.
When was Cardiobridge founded?
Cardiobridge was founded in 2016. It employs 11 to 50 people.
Where is Cardiobridge based?
Cardiobridge is headquartered in Hechingen, Germany, in the Europe region.
How does Cardiobridge make money?
One revenue line is on record: medical Device Sales.
Who are Cardiobridge's main competitors?
Emerging players on record are Magenta Medical and Evaheart Inc.. Broad incumbents are Medtronic, Getinge (Maquet), Terumo Cardiovascular, LivaNova (TLC / Caisson), Abbott (Cardiac Assist / HeartMate) and Abiomed (J&J MedTech). Direct peers are Berlin Heart and SynCardia Systems.
Does Cardiobridge have an API?
No public API is recorded for Cardiobridge.
What industry is Cardiobridge in?
Cardiobridge's product category is Mechanical Circulatory Support Devices. Its primary akta.pro industry code is HLAHAFAG, Mechanical Circulatory Support (VAD, IABP, ECMO), with a secondary code of HLAHAFAL, Cardiac Assist & Heart Failure Therapies (Implantables, Neuromodulation). Its NAICS code is 334510 and its SIC code is 3841.